Antimitotic Agents: all 5,052 studies that test it
Page 44 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung CancerCompletedNCT00160069Phase 2
- Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.TerminatedNCT00159471Not applicable
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast CancerStatus unknownNCT00159094Phase 2
- Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and CapecitabineCompletedNCT00156312Not applicable
- Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast CancerCompletedNCT00155259Phase 2
- Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast CancerStatus unknownNCT00154882Phase 2
- Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric CancerCompletedNCT00154778Phase 2
- Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal CancerCompletedNCT00154700Phase 2
- Weekly TP-HDFL in the Treatment of Advanced TCCCompletedNCT00154687Phase 2
- Navelbine and Capecitabine in the Treatment of Metastatic Breast CancerCompletedNCT00153907Phase 1
- Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate CancerCompletedNCT00151086Phase 1/2
- Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the ProstateCompletedNCT00151073Phase 2
- Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the ProstateCompletedNCT00151060Phase 2
- Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate CancerCompletedNCT00151047Phase 2
- Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2
- Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)CompletedNCT00148902Phase 1
- Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast CancerCompletedNCT00148070Phase 2
- Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's LymphomaCompletedNCT00147875Phase 1/2
- Uterine Papillary Serous Cancer (UPSC) TrialCompletedNCT00147680Phase 2
- Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast CancerCompletedNCT00146549Phase 3
- UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast CancerCompletedNCT00146042Phase 2
- Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue SarcomaCompletedNCT00142571Phase 3
- Docetaxel and Capecitabine in Advanced Gastric CancerCompletedNCT00142038Phase 2
- Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung CancerCompletedNCT00139711Phase 2
- Selective Dose Escalation for Esophageal CancerStatus unknownNCT00139633Phase 2
- Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139269Phase 1/2
- Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00139243Phase 1/2
- Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNCT00138242Phase 2
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
- Avastin and Taxotere for Esophagogastric CancerCompletedNCT00137813Phase 2
- Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic CancerCompletedNCT00137761Phase 2
- Neoadjuvant Therapy With Herceptin and Taxol for Breast CancerCompletedNCT00136539Phase 2
- Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate CancerCompletedNCT00136526Phase 2
- SB-743921 In Patients With Solid TumorsCompletedNCT00136513Phase 1
- Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the BladderCompletedNCT00136175Phase 2
- A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerCompletedNCT00134706Phase 2
- Study of Gemcitabine and Vinorelbine in Soft Tissue SarcomasCompletedNCT00134641Phase 2
- Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate CancerTerminatedNCT00132756Phase 1/2
- ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00132379Phase 1
- Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)Status unknownNCT00131053Phase 2
- A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid MalignanciesCompletedNCT00130169Phase 1
- Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast CancerCompletedNCT00129922Phase 3
- Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer PatientsCompletedNCT00129896Phase 1/2
- Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer PatientsCompletedNCT00128856Phase 2
- Study of Colchicine to Treat Acute Pericarditis and Prevent RecurrencesCompletedNCT00128453Phase 3
- Study of Colchicine to Prevent the Postpericardiotomy SyndromeCompletedNCT00128427Phase 3
- Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)CompletedNCT00128414Phase 3
- Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)CompletedNCT00128037Phase 2
- Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer PatientsSuspendedNCT00127088Phase 2
- Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's LymphomaTerminatedNCT00126243Phase 2
- Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate CancerTerminatedNCT00126230Phase 2
- Study of Satraplatin (JM-216) in Combination With DocetaxelTerminatedNCT00125411Phase 1
- Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast CancerCompletedNCT00123929Phase 2
- An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid MalignanciesCompletedNCT00121732Phase 1
- Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate CancerStatus unknownNCT00121095Phase 1/2
- Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary OriginWithdrawnNCT00119314Phase 2
- Ispinesib In Combination With Capecitabine In Patients With Solid TumorsCompletedNCT00119171Phase 1
- Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate CancerCompletedNCT00115635Phase 1/2
- Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)CompletedNCT00115414Phase 2
- Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast CancerCompletedNCT00114816Phase 3
- Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural EffusionCompletedNCT00114205Phase 1
- Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00114192Phase 2
- Study of TPI 287 in Patients With Advanced MalignanciesCompletedNCT00113724Phase 1
- Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid TumorsCompletedNCT00113438Phase 2
- Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00113347Phase 1
- Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00111904Phase 2
- Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast CancerCompletedNCT00111787Phase 2
- Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral RetinoblastomaActive, not recruitingNCT00110110Phase 2
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00107510Phase 2
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00107341Phase 2
- Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00107094Phase 1
- Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate CancerCompletedNCT00104715Phase 3
- Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00104624Phase 2
- A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)CompletedNCT00104364Phase 1
- Study of KOS-862 (Epothilone D) in Metastatic Prostate CancerTerminatedNCT00104130Phase 2
- Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast CancerCompletedNCT00103233Phase 3
- Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00101608Phase 2
- SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's LymphomaTerminatedNCT00101244Phase 1
- Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaCompletedNCT00101127Phase 2
- Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced CancerCompletedNCT00100139Phase 1
- Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung CancerTerminatedNCT00099879Phase 2
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00099086Phase 1
- SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic SyndromesCompletedNCT00098826Phase 1
- Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00097851Phase 2
- Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian CancerCompletedNCT00097409Phase 2
- Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00097227Phase 2
- Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast CancerCompletedNCT00096668Phase 2
- SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or PaclitaxelCompletedNCT00096499Phase 2
- Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast CancerCompletedNCT00096343Phase 2
- Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid TumorsCompletedNCT00096317Phase 1
- Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate CancerTerminatedNCT00096304Phase 1
- SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver CancerCompletedNCT00095992Phase 2
- SB-715992 in Treating Patients With Metastatic or Recurrent Malignant MelanomaCompletedNCT00095953Phase 2
- Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00095914Phase 1
- Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCompletedNCT00093119Phase 2
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00091377Phase 1/2
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00088998Phase 2
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerTerminatedNCT00088933Phase 1
- Study Evaluating MST-997 in Advanced Malignant Solid TumorsTerminatedNCT00088647Phase 1